Group 1 - Weigao Group has signed a non-binding letter of intent for a potential acquisition of 100% equity in Shandong Weigao Purui Pharmaceutical Packaging Co., Ltd by Weigao Blood Purification [1] - The potential transaction involves issuing consideration shares to Weigao Purui shareholders, which include Weigao Group and its affiliates [1] - Weigao Blood Purification is primarily engaged in the research, production, and sales of medical products for blood purification, including hemodialysis devices and peritoneal dialysis solutions [1] Group 2 - Weigao Purui focuses on the research, production, and sales of pre-filled drug delivery systems and automatic safety drug delivery systems, providing comprehensive drug delivery solutions for global biopharmaceutical companies [2] - As of the announcement date, Weigao Purui is a non-wholly owned subsidiary of the company, with ownership stakes of 94.0706%, 4.0215%, and 1.9078% held by the company, Weihai Shengxi, and Weihai Ruiming, respectively [2]
威高股份(01066.HK)威高普瑞拟出售山东威高普瑞医药包装100%的股权